Peptide Blend Guidance
Immune Shield Patient Guide
T-cell restore + cytokine brake — Thymosin Alpha-1, Thymalin, and KPV. The core immune unit; not a complete reconstitution kit (Thymulin and LL-37 stay sequential adjuncts).
Immune Shield (Thymosin Alpha-1 + Thymalin + KPV)
Blend Guidance Document — Patient Education
What Is This Blend?
Immune Shield is a three-peptide combination used for T-cell restoration with a built-in inflammation brake.
It is not a complete immune-system rebuild by itself. It covers three jobs at once:
- Activate adaptive surveillance (Thymosin Alpha-1)
- Prime and balance the thymus (Thymalin)
- Calm excess cytokine noise (KPV)
You may hear this referred to as Immune Shield or catalog code IMSH15 in your protocol or product materials.
| Catalog name | Thymosin Alpha-1 + Thymalin + KPV |
| Abbreviation | IMSH15 |
| Category | Peptide Blend |
| Regulatory status | Research (research / educational context) |
| Typical research pricing | $197/kit |
Components
This blend combines:
- Thymosin Alpha-1 — 5 mg — Helps immature T-cells mature and supports dendritic cells and NK cells. This is the most studied thymic peptide in this kit (approved in many countries as thymalfasin / Zadaxin for selected indications; that approval does not apply to this research blend).
- Thymalin — 5 mg — A thymic polypeptide extract (a mixture, not one molecule). Used as a broad “wake-up” and balancing signal for thymic output. Not the same as Thymulin.
- KPV — 5 mg — A short fragment of alpha-MSH that helps quiet inflammatory signaling (NF-κB / TNF-α, IL-6, IL-1β), especially along the gut–immune axis.
Related tags: Thymosin Alpha-1, Thymalin, KPV
How It Is Intended to Work
Think of Immune Shield as restore without lighting a fire:
| Layer | Peptide | Plain-language job |
|---|---|---|
| Adaptive activation | Thymosin Alpha-1 | Train and turn on T-cell / NK surveillance |
| Thymic capacity | Thymalin | Prime the thymus so output is broader and more balanced |
| Regulation | KPV | Keep inflammatory “noise” from running the show |
Mechanism confidence (catalog scale 1–5): 5 for complementary layering. Combination synergy is inferred from each peptide’s biology plus clinical education — not a large RCT of this exact trio.
What This Blend Does Not Do
Complete immune repair often needs steps this vial does not contain:
| Later / adjunct piece | Why it is separate |
|---|---|
| Barrier repair (often BPC-157) | Most immune education happens in the gut lining. Shield does not rebuild that lining. |
| Thymulin + zinc | A different peptide. It differentiates T-cells into working subtypes (including regulatory cells). It is zinc-dependent and usually comes after priming — not on day one. |
| LL-37 | Innate / antimicrobial / antigen-presentation support. Used when chronic infection or biofilm is part of the story — not a default add-on. |
Your practitioner decides if and when those belong in your protocol.
Potential Benefits (educational)
- Support for T-cell and NK cell function
- Thymic output and immune-aging conversations
- Cytokine balance (activation and a brake)
- Post-viral recovery education when immune tone is low and residual inflammation is present
Individual results vary. This list is not a promise of outcome.
Delivery
- Routes commonly used for this blend: subcutaneous (SC)
- Always follow the exact dose, timing, and route prescribed by your licensed practitioner.
- Do not change reconstitution water, dose, or injection site protocol without guidance.
What to Expect
- Response timelines vary. Some people notice energy or illness-resilience changes over weeks; immune lab shifts, if they occur, are usually measured over months.
- Track sleep, energy, new infections, flare symptoms, and injection-site reactions if your practitioner asks.
- If you have an autoimmune diagnosis, this blend’s Thymosin Alpha-1 component can be activating. Your practitioner may start with calmer peptides first, or use a different sequence.
Precautions
- This information is for education and does not replace medical advice.
- Research peptides and compounded products are not FDA-approved for all labeled uses; availability varies by jurisdiction.
- Tell your practitioner about all medications, supplements, pregnancy or nursing status, transplant history, and cancer history before starting.
- Discontinue and contact your provider for severe allergic symptoms (rash, swelling, difficulty breathing).
- Thymalin is not Thymulin. Do not substitute one for the other.
- Organ-transplant recipients and people with active malignancy need specialist review before immune-activating peptides.
Working With Your Practitioner
Your PeptidesPro protocol report (if provided) is the authority for your dose and schedule. This blend guide explains what the combination is for so you can ask better questions and follow instructions safely.
Questions worth asking:
- Is Immune Shield the right phase for me, or do I need gut / inflammation reset first?
- Do I need Thymulin + zinc later, or LL-37 if infections are part of the picture?
- What labs will we watch (for example CBC, CD4/CD8, CRP, immunoglobulins)?
Practitioners: see the companion reference Immune Shield — Complete Repair vs Dysfunction.
Important Disclosures
- These statements have not been evaluated by the U.S. Food and Drug Administration (FDA).
- This guide does not diagnose, treat, cure, or prevent any disease.
- Compounding and research-use availability vary by state and country.
- Always work with a licensed healthcare provider when initiating or changing peptide therapy.
This guide was prepared for patient education using PeptidesPro.
It does not constitute medical advice. Always follow your practitioner's personalized recommendations.